Drug Information

Drug General Information
Drug ID
D01KKI
Former ID
DIB015597
Drug Name
SGN-CD33A
Drug Type
Antibody
Indication Acute myeloid leukemia [ICD9: 205; ICD10:C92.0] Phase 1 [549492]
Company
Seattle genetics
Target and Pathway
Target(s) Myeloid cell surface antigen CD33 Target Info [532400]
KEGG Pathway Hematopoietic cell lineage
Reactome Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
References
Ref 549492Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800038378)
Ref 532400SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML. Blood. 2013 Aug 22;122(8):1455-63.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.